Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 17, 2024 11:19 ET | Source: Brain & Behavior Research Foundation

Brain & Behavior Research Foundation International Mental Health Research Symposium Featuring Talks on Psychosis, Child and Adolescent Psychiatry, Mood Disorders and More

New York, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) International Mental Health Research Symposium will be held on Friday, October 25, 2024, at the...
June 30, 2022 09:00 ET | Source: Brain & Behavior Research Foundation

When Medicine is Not Enough for Schizophrenia and Psychosis

New York, June 30, 2022 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “When Medicine is Not Enough for Schizophrenia and Psychosis” on Tuesday,...
July 08, 2021 09:00 ET | Source: Brain & Behavior Research Foundation

Cognitive Impairment in Psychosis: What it is and How it's Treated - A Free Webinar from the Brain & Behavior Research Foundation

New York, July 08, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Cognitive Impairment in Psychosis: What it is and How it's Treated” on...
August 02, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related Psychosis

NEW YORK, Aug. 02, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a...
April 13, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at Harvard

NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that Dr. Ilya Reznik, a...
February 02, 2017 13:33 ET | Source: Canadian Consortium for Early Intervention in Psychosis

Access to Cannabis Should Not Occur Prior to Age 21, according to a position statement by the Canadian Consortium for Early Intervention in Psychosis

HAMILTON, Ontario, Feb. 02, 2017 (GLOBE NEWSWIRE) -- In response to the recommendations of the Task Force on Marijuana Legalization and Regulation, the Canadian Consortium for Early Intervention in...